Follow the BIOMERICA INC stock price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €4.6m. The latest transaction was disclosed on 27 August 2026 (Acquisition). Among the most active insiders: Irani Zackary S.. Every trade is free.
28
Insider Decl.
n/a
Thresholds
€171,108
16 ops.
Buy Volume
n/a
n/a
Sell Volume
53Σ signal
Buys €171,108n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,992 of 29,064 companies
3.6
score / 100
Value
3
Quality
4
FCF yld-59%
Earn yld-75%
EV/EBITDA·
ROE-94%
Gross mgn9.4%
Net mgn-94%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1,538 shares@ US$2.9411.3% of flowCommon StockSEC:0001513162-23-000011:0
Canonical exit: 27 Apr 2023 (T+90)
25 of 28 declarations
Acerca de BIOMERICA INC
BIOMERICA INC es una empresa centrada en el desarrollo y la fabricación de pruebas de diagnóstico para la salud humana. Opera principalmente en el mercado de Estados Unidos.